Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure
NCT: NCT07792746 · RECRUITING
Brief Summary
Obstructive sleep apnea (OSA) is commonly assessed using the apnea-hypopnea index, although this measure does not fully reflect cardiovascular risk or the physiological impact of the disease. Emerging biomarkers, including sleep apnea-specific hypoxic burden, pulse wave amplitude drop index, and heart rate response, may provide additional information on cardiovascular vulnerability. This prospective multicenter observational study will investigate the association between these biomarkers, measured from the diagnostic sleep study, and adherence to continuous positive airway pressure (CPAP) therapy after three months. Symptoms, quality of life, clinical characteristics, and changes in biomarkers under continuous positive airway pressure will also be evaluated.
Frequently Asked Questions
What is Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure?
Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure is a clinical trial registered under NCT07792746. Current status: RECRUITING.
What is the status of NCT07792746?
The current status of NCT07792746 (Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure) is: RECRUITING.
When did Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure start?
Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure started on 2026-02-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.